<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00413465</url>
  </required_header>
  <id_info>
    <org_study_id>RPF.sa.cim.rh.dk</org_study_id>
    <nct_id>NCT00413465</nct_id>
  </id_info>
  <brief_title>Study of Renal Blood Flow During Human Endotoxemia</brief_title>
  <official_title>Renal Plasma Flow During Experimental Human Endotoxemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <brief_summary>
    <textblock>
      The purpose of the present protocol is to study whether endotoxemia will affect the renal
      blood flow in type 2 diabetics and healthy volunteers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Many septic patients develop acute renal failure and the risk is higher in patients with
      diabetes. The pathogenetic mechanisms behind the development of acute renal failure in
      connection with sepsis is not completely understood. One among many possible explanations is
      a change in renal hemodynamics. However, it is still largely unknown what happens to the
      renal plasma flow during human sepsis. In this study we give endotoxin injection (0,3 ng/kg)
      to type 2 diabetics and healthy controls as an experimental model of sepsis. Renal plasma
      flow and glomerular filtration rate are measured by DTPA-renography 1 day before before and
      1,25 and 6,5 hours after injection of endotoxin. Furthermore WBC,
      plasma-cytokines,VCAM-1/ICAM-1, endothelin-1, Thromboxane B2, angiotensin 2, renin and PAI-1
      are measured on an hourly basis up to 8 hours after endotoxin injection.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2006</start_date>
  <completion_date>December 2007</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Renal plasma flow, Glomerular filtration rate, Plasma cytokine content, Endotoxemia score, Plasma angiotensin II and renin content, Plasma thromboxane B2 content, Plasma PAI-1 content</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean arterial pressure, Heart rate, Oxygen saturation, Body temperature,</measure>
  </secondary_outcome>
  <enrollment>32</enrollment>
  <condition>Healthy</condition>
  <condition>Type 2 Diabetes</condition>
  <condition>Endotoxemia</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Escherichia Coli Endotoxin</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy

          -  Type 2 diabetes

        Exclusion Criteria:

          -  Renal failure

          -  Heart failure

          -  Lung disease
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne Sofie Andreasen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anne Sofie Andreasen, MD</last_name>
    <phone>+45 3545 1616</phone>
    <email>sofie_andreasen@msn.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bente K Pedersen, Professor</last_name>
    <phone>+45 3545 7621</phone>
    <email>bkp@rh.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Intensiv Care Unit, Rigshospitalet,</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Anne Sofie Andreasen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>December 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 18, 2006</study_first_submitted>
  <study_first_submitted_qc>December 18, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 19, 2006</study_first_posted>
  <last_update_submitted>December 18, 2006</last_update_submitted>
  <last_update_submitted_qc>December 18, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 19, 2006</last_update_posted>
  <keyword>Renal Plasma Flow</keyword>
  <keyword>Endotoxemia</keyword>
  <keyword>Type 2 diabetes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Endotoxemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

